CHF51.90
Download est disponible immédiatement
Metabolic Inhibitors: A Comprehensive Treatise, Volume I focuses on the properties of inhibitors of metabolic processes or enzyme systems. The book explores a wide range of substances that interfere with (and usually retard) metabolic and enzymic processes, emphasizing the inhibitor rather than the metabolic or enzymic system that is affected.
Organized into 15 chapters, this volume begins with a historical overview of research on the mode of action of biological inhibitors, touching on the principle of competitive inhibition by structural analogues. The book then turns to the concept of a competitive enzymic relationship by growth inhibitory analogues and their corresponding amino acids; the metabolic inhibitory effects of polypeptides and proteins; and the use of pentoses as analogues in carbohydrate metabolism. The reader is also introduced to the metabolic inhibitory effects of fatty acids; the intermediary metabolism of phospholipids; and the inhibition of purine and pyrimidine analogues. The remaining chapters discuss the role of nucleic acids and nucleoproteins in the regulation of cellular metabolism and the inhibition of amino acid decarboxylases, cholesterol, and steroid biosynthesis.
This book will be of value to biochemists, advanced students, medical research workers, and research workers in the various fields of biological chemistry, as well as those working in the microbiological, botanical, and other agricultural fields.
Contenu
List of Contributors
Preface and Introduction
Contents of Volume II
Chapter 1 Amino Acid Analogues
I. Introduction
II. Amino Acid Antagonists
III. Antagonisms among Amino Acids Essential for Protein Synthesis
IV. Biological Studies Involving Amino Acid Inhibitors
References
Chapter 2 Polypeptides and Proteins as Inhibitors
I. Introduction
II. Polypeptide Antibiotics
III. Natural Protein and Polypeptide Inhibitors
IV. Synthetic Poly-a-Amino Acids
V. Analogues of the Polypeptide and Protein Hormones
VI. Modified Enzymes as Inhibitors
VII. Miscellaneous Di-and Tripeptide Inhibitors
VIII. Concluding Remarks
References
Chapter 3 Hexose and Pentose Analogues
I. Introduction
II. Hexoses
III. Pentoses
IV. Conclusions
References
Chapter 4 Fatty Acids and Their Analogues
I. Metabolic Inhibitory Effects of Normal Fatty Acids
II. Metabolic Inhibitory Effects of Acyl Coenzyme a Derivatives
III. Fatty Acid Analogues
References
Chapter 5 Phospholipids
I. Phospholipid Catabolism
II. Phospholipid Synthesis
III. Ion Transport and Phospholipid Metabolism
IV. Alternative Pathway for Lecithin Synthesis; Transmethylation Involving Glycerophosphatides
V. Conclusions
References
Chapter 6 Purine Analogues
I. Introduction
II. Cellular Multiplication
III. Effects in the Whole Organism
IV. Effects on Function
V. Biochemical Effects
VI. Conclusion
References
Chapter 7 Pyrimidine Analogues
I. Introduction
II. Biosynthesis and Metabolic Functions of Pyrimidine Nucleotides
III. Pyrimidine Analogues
IV. Other Inhibitors of Pyrimidine Nucleotide Biosynthesis
References
Chapter 8 Nucleic Acids and Nucleoproteins
I. Introduction
II. The Nucleic Acids: Their Role in the Control of Cellular Metabolism
III. Virus Infection
References
Chapter 9 Inhibition of Amino Acid Decarboxylases
I. Introduction
II. Pyridoxal Kinase
III. Apoenzyme-Coenzyme Dissociation
IV. Transport, Uptake, Binding, Release
V. Inanition
VI. Tissue Damage, Growth, Neoplasms, Organectomy
VII. Apoenzyme Synthesis
VIII. Inhibition by Apoenzyme Antibody
IX. Metals, Chelators, and Metal Complexers
X. Cyanide
XI. Pyridoxal-5-Phosphate (Codecarboxylase), Vitamin B6, B6-Deficiency, B6-Antagonists
XII. Activators, Stabilizers, and Cofactors Other Than B6-P04
XIII. Carbonyl Reagents and Inhibitors Acting on Coenzyme Other Than Cyanide, Substrate Analogues, and Pyridoxine Antagonists
XIV. Hormones
XV. Miscellaneous
XVI. Substrate Analogues
References
Chapter 10 Inhibitors, Antagonists, and Inactivators in the Etiology of Diabetes Mellitus in Man
I. Introduction
II. Insulinogenesis
III. Release of Insulin
IV. Impairment of Insulinogenesis
V. Impairment of Insulin Release
VI. Impairment in Transport of Insulin
VII. Inhibitors of Insulin
VIII. Impairment of Insulin Receptor Sites
IX. Antagonists of Action of Insulin
X. Excretion of Insulin
XI. Degradation of Insulin
XII. Inhibitors of Insulin Degradation
XIII. Summary
References
Chapter 11 Antagonists and Inhibitors of the Fat-soluble Vitamins
I. Vitamin A
II. Vitamin D
III. Vitamin
IV. Vitamin
References
Chapter 12 Antimetabolites of the Water-soluble Vitamins
I. General Principles of Antimetabolite Action
II. Antimetabolites of Water-soluble Vitamins
References
Chapter 13 Sulfonamides and Folic Acid Antagonists
I. Introduction
II. Sulfonamides
III. Folic Acid in Enzymic Reactions
IV. Folic Acid Antagonists
References
Chapter 14 Thyroxine Analogues
I. Introduction
II. Techniques of Evaluating Thyroxine Inhibitors
III. Early Studies of Compounds Related to Diiodotyrosine
IV. Ethers of Diiodotyrosine and Related Compounds
V. Derivatives of Diiodohydroxybenzoic Acid
VI. Iodinated Phenoxyacetic Acids
VII. Partially Iodinated Thyronines and Related Compounds
VIII. General Survey of Inhibitory Structures
References
Chapter 15 Inhibitors of Steroid Actions and Cholesterol and Steroid Biosynthesis
I. Introduction
II. Inhibition of Estrogenic Activity
III. Inhibition of Androgenic Activity
IV. Inhibition of Corticoid Activity
V. Inhibition of Steroid Biosynthesis
VI. Inhibition of Cholesterol Biosynthesis ·
References
Author Index
Subject Index